Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10911291 | Lung Cancer | 2013 | 6 Pages |
Abstract
Aurora-B is a key regulator of mitosis, and the overexpression has been detected in a variety of solid tumors. The Aurora-B overexpression has been suggested to correlate with clinical aggressiveness and aneuploidy in vitro, however, the frequency of overexpression of Aurora-B protein, the association with clinicopathologic parameters and aneuploidy remain poorly defined in non-small-cell lung cancer (NSCLC). Using 157 surgical specimens of human NSCLC, we here show that overexpression of Aurora-B proteins are significantly correlated with aneuploidy and poor outcomes in NSCLC. We examined immunohistochemical protein expression of Aurora-B, and DNA ploidy by laser scanning cytometry in 157 NSCLC cases. Aurora-B overexpression was found in 83 cases (53%) of NSCLC, and was significantly correlated with vascular invasion (p = 0.012), poor differentiation (p < 0.001), larger tumor size (p = 0.010) and lymph node metastasis (p = 0.05) and poor prognosis (p = 0.011). Aneuploidy was found in 87 cases (57%), and was significantly correlated with Aurora-B overexpression (p = 0.0065). Logistic multivariate analysis revealed overexpression of Aurora-B protein to be significant risk factors for aneuploidy compared with other factors. These results indicate that Aurora-B overexpression may contribute to malignant potential and increased aneuploidy in NSCLC. Thus, Aurora-B may serve as a new therapeutic target in against patients with NSCLC, although further studies will be necessary.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Masafumi Takeshita, Takaomi Koga, Koichi Takayama, Kayo Ijichi, Tokujiro Yano, Yoshihiko Maehara, Yoichi Nakanishi, Katsuo Sueishi,